Galectin-9 attenuates acute lung injury by expanding CD14- plasmacytoid dendritic cell-like macrophages

American Journal of Respiratory and Critical Care Medicine

Volumn 184, Issue 3, 2011, Pages 328-339

  Kojima, Keisuke ^a   Arikawa, Tomohiro ^b   Saita, Naoki ^a   Goto, Eisuke ^a   Tsumura, Shinsuke ^a   Tanaka, Reina ^a   Masunaga, Aiko ^a   Niki, Toshiro ^b,c   Oomizu, Souichi ^b   Hirashima, Mitsuomi ^b,c   Kohrogi, Hirotsugu ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

^c Research Center   (Japan)

Author keywords

Acute respiratory distress syndrome; CD11b; Gr 1; LPS

Indexed keywords

CD11B ANTIGEN; CD14 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CCR2; CYTOKINE; ECALECTIN; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 1BETA; INTERLEUKIN 6; KIDNEY INJURY MOLECULE 1; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHATE BUFFERED SALINE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; INOCULATION; KERATINOCYTE; LUNG LAVAGE; MACROPHAGE; MACROPHAGE FUNCTION; MOUSE; NONHUMAN; PATHOLOGY; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ACUTE LUNG INJURY; ANIMALS; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; GALECTINS; IMMUNITY, INNATE; INJECTIONS, SUBCUTANEOUS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED C57BL;

EID: 80051571292     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201010-1566OC     Document Type: Article

References (53)

1. Wada J, Kanwar YS. Identification and characterization of galectin-9, a novel β-galactoside-binding mammalian lectin. J Biol Chem 1997;272:6078-6086. (Pubitemid 27102450)
2. Cooper DN, Barondes SH. Evidence for export of a muscle lectin from cytosol to extracellular matrix and for a novel secretory mechanism. J Cell Biol 1990;110:1681-1691. (Pubitemid 20169506)
3. Seki M, Oomizu S, Sakata K, Sakata A, Arikawa T, Watanabe K, Ito K, Takeshita K, Niki T, Saita N, et al. Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin Immunol 2008;127:78-88.
4. Anderson AC, Anderson DE, Bregoli L, Hastings WD, Kassam N, Lei C, Chandwaskar R, Karman J, Su EW, Hirashima M, et al. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science 2007;318:1141-1143. (Pubitemid 350134897)
5. Zhu C, Anderson AC, Schubart A, Xiong H, Imitola J, Khoury SJ, Zheng XX, Strom TB, Kuchroo VK. The Tim-3 ligand galectin-9 negatively regulates T helper type-1 immunity. Nat Immunol 2005;6:1245-1252. (Pubitemid 43045636)
6. Kashio Y, Nakamura K, Abedin MJ, Seki M, Nishi N, Yoshida N, Nakamura T, Hirashima M. Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway. J Immunol 2003;170:3631-3636. (Pubitemid 36359232)
7. + immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res 2006;66:1123-1131.
8. + myeloid suppressor cells cause T cell dysfunction after traumatic stress. J Immunol 2006;176:2085-2094.
9. Movahedi K, Guilliams M, Van den Bossche J, Van den Bergh R, Gysemans C, Beschin A, De Baetselier P, Van Ginderachter J. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 2008;111:4233-4244.
10. Arikawa T, Saita N, Oomizu S, Ueno M, Matsukawa A, Katoh S, Kojima K, Nagahara K, Miyake M, Yamauchi A, et al. Galectin-9 expands immunosuppressive macrophages to ameliorate T-cell-mediated lung inflammation. Eur J Immunol 2010;40:548-558.
11. Nobumoto A, Oomizu S, Arikawa T, Katoh S, Nagahara K, Miyake M, Nishi N, Takeshita K, Niki T, Yamauchi A, et al. Galectin-9 expands unique macrophages exhibiting plasmacytoid dendritic cell-like phenotypes that activate NK cells in tumor-bearing mice. Clin Immunol 2009;130:322-330.
12. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD. Incidence and outcomes of acute lung injury. N Engl J Med 2005;353:1685-1693. (Pubitemid 41464707)
13. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000;342:1334-1349. (Pubitemid 30408719)
14. Chignard M, Balloy V. Neutrophil recruitment and increased permeability during acute lung injury induced by lipopolysaccharide. Am J Physiol Lung Cell Mol Physiol 2000;279:1083-1090.
15. Abraham E, Carmody A, Shenkar R, Arcaroli J. Neutrophil as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol 2000;279:1137-1145.
16. Wheeler AP, Bernard GR. Acute lung injury and acute respiratory distress syndrome: a clinical review. Lancet 2007;369:1553-1564. (Pubitemid 46670280)
17. 2-producing polymorphonuclear leukocytes. Clin Immunol 2007;124:221-233.
18. Nishi N, Itoh A, Fujiyama A, Yoshida N, Araya S, Hirashima M, Shoji H, Nakamura T. Development of highly stable galectins: truncation of the linker peptide confers protease-resistance on tandem-repeat type galectins. FEBS Lett 2005;579:2058-2064. (Pubitemid 40469670)
19. Szarka RJ, Wang N, Gordon L, Nation PN, Smith RH. A murine model of pulmonary damage induced by lipopolysaccharide via intranasal instillation. J Immunol Methods 1997;202:49-57. (Pubitemid 27104267)
20. Sinha P, Clements VK, Bunt SK, Albelda SM, Ostrand-Rosenberg S. Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J Immunol 2007;179:977-983.
21. Yamao T, Noguchi T, Takeuchi O, Nishiyama U, Morita H, Hagiwara T, Akahori H, Kato T, Inagaki K, Okazawa H, et al. Negative regulation of platelet clearance and of the macrophage phagocytic response by the transmembrane glycoprotein SHPS-1. J Biochem 2002;277:39833-39839.
22. Matsushita N, Nishi N, Seki M, Matsumoto R, Kuwabara I, Liu FT, Hata Y, Nakamura T, Hirashima M. Requirement of divalent galactoside-binding activity of ecalectin/galectin-9 for eosinophil chemoattraction. J Biol Chem 2000;275:8355-8360. (Pubitemid 30180176)
23. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997;388:394-397. (Pubitemid 27334820)
24. Pittet JF, Mackersie RC, Martin TR, Matthay MA. Biological markers of acute lung injury: prognostic and pathogenetic significance. Am J Respir Crit Care Med 1997;155:1187-1205. (Pubitemid 27172758)
25. Prescott SM, McIntyre TM, Zimmerman G. Two of the usual suspects, platelet-activating factor and its receptor, implicated in acute lung injury. J Clin Invest 1999;104:743-750.
26. Wu CL, Lin LY, Yang JS, Chan MC, Hsueh CM. Attenuation of lipopolysaccharide-induced acute lung injury by treatment with IL-10. Respirology 2009;14:511-521.
27. Schnyder-Candrian S, Quesniaux VF, Di Padova F, Maillet I, Noulin N, Couillin I, Erard RF, Vargaftig BB, Ryffel B, Schnyder B. Dual effects of p38 MAPK on TNF-dependent bronchoconstriction and TNF-independent neutrophil recruitment in lipopolysaccharide-induced acute respiratory distress syndrome. J Immunol 2005;175:262-269. (Pubitemid 40884327)
28. Tsuruta Y, Park YJ, Siegal GP, Liu G, Abraham E. Involvement of vitronectin in lipopolysaccharide-induced acute lung injury. J Immunol 2007;179:7079-7086.
29. Rittirsch D, Flierl MA, Day DE, Nadeau BA, McGuire SR, Hoesel LM, Ipaktchi K, Zetoune FS, Sarma JV, Leng L, et al. Acute lung injury induced by lipopolysaccharide is independent of complement activation. J Immunol 2008;180:7664-7672.
30. Katoh S, Ishii N, Nobumoto A, Takeshita K, Dai SY, Shinonaga R, Niki T, Nishi N, Tominaga A, Yamauchi A, et al. Galectin-9 inhibits CD44-hyaluronan interaction and suppresses a murine model of allergic asthma. Am J Respir Crit Care Med 2007;176:27-35. (Pubitemid 47048051)
31. Nobumoto A, Nagahara K, Oomizu S, Katoh S, Nishi N, Takeshita K, Niki T, Tominaga A, Yamauchi A, Hirashima M. Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices. Glycobiology 2008;18:735-744.
32. Khan AI, Kerfoot SM, Heit B, Liu L, Andonegui G, Ruffell B, Johnson P, Kubes P. Role of CD44 and hyaluronan in neutrophil recruitment. J Immunol 2004;173:7594-7601. (Pubitemid 39628201)
33. Dalton DK, Haynes L, Chu CQ, Swain SL, Wittmer S. Interferon γ eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells. J Exp Med 2000;192:117-122. (Pubitemid 30470812)
34. + cells: a potential mechanism for immune polarization in helminth infections. J Immunol 2001;167:5294-5303.
35. +immature myeloid suppressor cells. Int Immunol 2002;14:1125-1134.
36. Melani C, Sangaletti S, Barazzetta FM, Werb Z, Colombo MP. Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma. Cancer Res 2007;67:11438-11446. (Pubitemid 350248572)
37. Asselin-Paturel C, Brizard G, Pin JJ, Brière F, Trinchieri G. Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody. J Immunol 2003;171:6466-6477. (Pubitemid 37532075)
38. Giamarellos-Bourboulis EJ, Tsaganos T, Spyridaki E, Mouktaroudi M, Plachouras D, Vaki I, Karagianni V, Antonopoulou A, Veloni V, Giamarellou H. Early changes of CD4-positive lymphocytes and NK cells in patients with severe gram-negative sepsis. Crit Care 2006;10:R166.
39. Parker LC, Whyte MK, Vogel SN, Dower SK, Sabroe I. Toll-like receptor (TLR) 2 and TLR4 agonists regulate CCR expression in human monocytic cells. J Immunol 2004;172:4977-4986. (Pubitemid 38456424)
40. Lund JM, Alexopoulou L, Sato A, Karow M, Adams NC, Gale NW, Iwasaki A, Flavell RA. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci USA 2004;101:5598-5603. (Pubitemid 38481202)
41. Le Goffic R, Balloy V, Lagranderie M, Alexopoulou L, Escriou N, Flavell R, Chignard M, Si-Tahar M. Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog 2006;2:e53.
42. Ramaprakash H, Ito T, Standiford TJ, Kunkel SL, Hogaboam CM. Toll-like receptor 9 modulates immune responses to Aspergillus fumigatus conidia in immunodeficient and allergic mice. Infect Immun 2009;77:108-119.
43. Murray LA, Knight DA, McAlonan L, Argentieri R, Joshi A, Shaheen F, Cunningham M, Alexopolou L, Flavell RA, Sarisky RT, et al. Deleterious role of TLR3 during hyperoxia-induced acute lung injury. Am J Respir Crit Care Med 2008;178:1227-1237.
44. Goyert SM, Ferrero E, Rettig WJ, Yenamandra AK, Obata F, Le Beau MM. The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors. Science 1988;29:497-500. (Pubitemid 18084313)
45. Ishii Y, Wang Y, Haziot A, del Vecchio PJ, Goyert SM, Malik AB. Lipopolysaccharide binding protein and CD14 interaction induces tumor necrosis factor-α generation and neutrophil sequestration in lungs after intratracheal endotoxin. Circ Res 1993;73:15-23. (Pubitemid 23173052)
46. Knuefermann P, Nemoto S, Misra A, Nozaki N, Defreitas G, Goyert SM, Carabello BA, Mann DL, Vallejo JG. CD14-deficient mice are protected against lipopolysaccharide-induced cardiac inflammation and left ventricular dysfunction. Circulation 2002;106:2608-2615. (Pubitemid 35340698)
47. Moore KJ, Andersson LP, Ingalls RR, Monks BG, Li R, Arnaout MA, Golenbock DT, Freeman MW. Divergent response to LPS and bacteria in CD14-deficient murine macrophages. J Immunol 2000;165:4272-4280.
48. Pickl WF, Majdic O, Kohl P, Stöckl J, Riedl E, Scheinecker C, Bello-Fernandez C, Knapp W. Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes. J Immunol 1996;157:3850-3859. (Pubitemid 126449292)
49. +cell line (XS52) by IL-4, TNF-α, IL-1β, and agonistic anti-CD40 monoclonal antibody. J Immunol 1999;163:5331-5337.
50. Dai SY, Nakagawa R, Itoh A, Murakami H, Kashio Y, Abe H, Katoh S, Kontani K, Kihara M, Zhang SL, et al. Galectin-9 induces maturation of human monocyte-derived dendritic cells. J Immunol 2005;175:2974-2981. (Pubitemid 41170515)
51. Mahnke K, Becher E, Ricciardi-Castagnoli P, Luger TA, Schwarz T, Grabbe S. CD14 is expressed by subsets of murine dendritic cells and upregulated by lipopolysaccharide. Adv Exp Med Biol 1997;417:145-159. (Pubitemid 27427735)
52. Zanoni I, Ostuni R, Capuano G, Collini M, Caccia M, Ronchi AE, Rocchetti M, Mingozzi F, Foti M, Chirico G, et al. CD14 regulates the dendritic cell life cycle after LPS exposure through NFAT activation. Nature 2009;460:264-268.
53. + Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. J Clin Invest 2009;119:2898-2913.